Public Health in Danger with Move of Pharmaceutical Policy to DG Enterprise and Industry

Health Action International is appalled by the European Commission’s opaque and unjustified
decision to move SANCO Units D5 (Medicinal Products–Authorisations, European Medicines
Agency) and D6 (Medicinal Products–Quality, Safety and Efficacy) from the Directorate General (DG) for Health and Consumers to DG Enterprise and Industry.

Read more…

START TYPING AND PRESS ENTER TO SEARCH